title: Advances in Clinical Mass Spectrometry.
abstract: Although mass spectrometry has been used clinically for decades, the advent of immunoassay technology moved the clinical laboratory to more labor saving automated platforms requiring little if any sample preparation. It became clear, however, that immunoassays lacked sufficient sensitivity and specificity necessary for measurement of certain analytes or for measurement of analytes in specific patient populations. This limitation prompted clinical laboratories to revisit mass spectrometry which could additionally be used to develop assays for which there was no commercial source. In this chapter, the clinical applications of mass spectrometry in therapeutic drug monitoring, toxicology, and steroid hormone analysis will be reviewed. Technologic advances and new clinical applications will also be discussed.
authors.affiliation: University of California San Francisco, San Francisco, CA, United States. Electronic address: deborah.french@ucsf.edu.
authors.forename: D
authors.initials: D
authors.lastname: French
mesh_terms: D019963:Clinical Chemistry Tests; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods*
keywords: High-resolution mass spectrometry; Immunoassay; LC-MS/MS; Mass spectrometry; Steroid hormones; Therapeutic drug monitoring; Thyroid hormones; Toxicology